LabConnect has now launched SampleGISTICS 2.0, a highly advanced mobile application that aims to replace digital pen technology with a digital solution for participant sample information, thereby eliminating paper requisitions and data entry. The application provides real-time visibility into sample status and stability, starting from sample collection and ending with laboratory intake. This modernization addresses critical bottlenecks such as lost samples and delayed shipments. “SampleGISTICS 2.0 is the result of our more than two decades of experience managing decentralized clinical trials across our global network of laboratories, couriers and operations,” said Wes Wheeler, chief executive officer of LabConnect. “That level of expertise and integration made it possible to develop a new application designed specifically for clinical trials by digitizing sample capture at the collection point.”
Also Read: ChargePoint Introduces Intelligent EV Charger Management Tools
“SampleGISTICS 2.0 simplifies how sites handle study visit and participant data at the point of collection, securely transferring it into LabConnect’s validated LIMS environment,” said Charles Castano, chief technology officer at LabConnect. “By leveraging technology to streamline data capture at the site, we can significantly reduce queries and gain visibility into samples arriving close to expiration windows that require priority processing. This also reduces manual steps, provides immediate sample traceability, enables real-time data capture, and supports faster, more reliable laboratory results.” The platform further supports global compliance through multilingual support and offline functionality.
